<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36575437</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1477-7525</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>27</Day></PubDate></JournalIssue><Title>Health and quality of life outcomes</Title><ISOAbbreviation>Health Qual Life Outcomes</ISOAbbreviation></Journal><ArticleTitle>Evaluating fatigue in patients recovering from COVID-19: validation of the fatigue severity scale and single item screening questions.</ArticleTitle><Pagination><StartPage>170</StartPage><MedlinePgn>170</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">170</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12955-022-02082-x</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Fatigue is a common symptom in hospitalized and non-hospitalized patients recovering from COVID-19, but no fatigue measurement scales or questions have been validated in these populations. The objective of this study was to perform validity assessments of the fatigue severity scale (FSS) and two single-item screening questions (SISQs) for fatigue in patients recovering from COVID-19.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We examined patients &#x2265;&#x2009;28&#xa0;days after their first SARS-CoV-2 infection who were hospitalized for their acute illness, as well as non-hospitalized patients referred for persistent symptoms. Patients completed questionnaires through 1 of 4 Post COVID-19 Recovery Clinics in British Columbia, Canada. Construct validity was assessed by comparing FSS scores to quality of life and depression measures. Two SISQs were evaluated based on the ability to classify fatigue (FSS score &#x2265;&#x2009;4).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Questionnaires were returned in 548 hospitalized and 546 non-hospitalized patients, with scores computable in 96.4% and 98.2% of patients respectively. Cronbach's alpha was 0.96 in both groups. The mean&#x2009;&#xb1;&#x2009;SD FSS score was 4.4&#x2009;&#xb1;&#x2009;1.8 in the hospitalized and 5.2&#x2009;&#xb1;&#x2009;1.6 in the non-hospitalized group, with 62.5% hospitalized and 78.9% non-hospitalized patients classified as fatigued. Ceiling effects were 7.6% in the hospitalized and 16.1% in non-hospitalized patients. FSS scores negatively correlated with EQ-5D scores in both groups (Spearman's rho -&#xa0;0.6 in both hospitalized and non-hospitalized; p&#x2009;&lt;&#x2009;0.001) and were higher among patients with a positive PHQ-2 depression screen (5.4 vs. 4.0 in hospitalized and 5.9 vs. 4.9 in non-hospitalized; p&#x2009;&lt;&#x2009;0.001). An SISQ asking whether there was "fatigue present" had a sensitivity of 70.6% in hospitalized and 83.2% in non-hospitalized patients; the "always feeling tired" SISQ, had a sensitivity of 70.5% and 89.6% respectively.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Fatigue was common and severe in patients referred for post COVID-19 assessment. Overall, the FSS is suitable for measuring fatigue in these patients, as there was excellent data quality, strong internal consistency, and construct validity. However, ceiling effects may be a limitation in the non-hospitalized group. SISQs had good sensitivity for identifying clinically relevant fatigue in non-hospitalized patients but only moderate sensitivity in the hospitalized group, indicating that there were more false negatives.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Naik</LastName><ForeName>Hiten</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of British Columbia, 2775 Laurel Street, Vancouver, BC, V5Z 1M9, Canada. hitennaik123@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shao</LastName><ForeName>Selena</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Provincial Health Services Authority, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tran</LastName><ForeName>Karen C</ForeName><Initials>KC</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of British Columbia, 2775 Laurel Street, Vancouver, BC, V5Z 1M9, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of General Internal Medicine, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Alyson W</ForeName><Initials>AW</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of British Columbia, 2775 Laurel Street, Vancouver, BC, V5Z 1M9, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Russell</LastName><ForeName>James A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of British Columbia, 2775 Laurel Street, Vancouver, BC, V5Z 1M9, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Critical Care Medicine, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khor</LastName><ForeName>Esther</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Provincial Health Services Authority, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nacul</LastName><ForeName>Luis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of British Columbia, 2775 Laurel Street, Vancouver, BC, V5Z 1M9, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Provincial Health Services Authority, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McKay</LastName><ForeName>R Jane</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of British Columbia, 2775 Laurel Street, Vancouver, BC, V5Z 1M9, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of General Internal Medicine, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carlsten</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of British Columbia, 2775 Laurel Street, Vancouver, BC, V5Z 1M9, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vancouver Coastal Health Research Institute, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryerson</LastName><ForeName>Christopher J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of British Columbia, 2775 Laurel Street, Vancouver, BC, V5Z 1M9, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levin</LastName><ForeName>Adeera</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of British Columbia, 2775 Laurel Street, Vancouver, BC, V5Z 1M9, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Provincial Health Services Authority, Vancouver, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Nephrology, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Health Qual Life Outcomes</MedlineTA><NlmUniqueID>101153626</NlmUniqueID><ISSNLinking>1477-7525</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011594" MajorTopicYN="N">Psychometrics</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Fatigue severity scale</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Psychometrics</Keyword><Keyword MajorTopicYN="N">Quality of life</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>The authors have no competing interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>27</Day><Hour>23</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36575437</ArticleId><ArticleId IdType="pmc">PMC9792925</ArticleId><ArticleId IdType="doi">10.1186/s12955-022-02082-x</ArticleId><ArticleId IdType="pii">10.1186/s12955-022-02082-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Crook H, Raza S, Nowell J, et al. Long covid&#x2014;Mechanisms, risk factors, and management. BMJ. 2021;374:1&#x2013;18. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open. 2021;4:1&#x2013;19. doi: 10.1001/jamanetworkopen.2021.11417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A, Wamil M, Alberts J, et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021;11:2&#x2013;7. doi: 10.1136/bmjopen-2020-048391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-048391</ArticleId><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun LL, Wang J, Wang YS, et al. Symptomatic features and prognosis of 932 hospitalized patients with coronavirus disease 2019 in Wuhan. J Dig Dis. 2021;22:271&#x2013;281. doi: 10.1111/1751-2980.12983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1751-2980.12983</ArticleId><ArticleId IdType="pmc">PMC8251293</ArticleId><ArticleId IdType="pubmed">33742780</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz YMJ, Van Herck M, Delbressine JM, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020;6:00542&#x2013;02020. doi: 10.1183/23120541.00542-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542-2020</ArticleId><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. N Engl J Med. 2020;383:299&#x2013;302. doi: 10.1056/nejmp2014836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmp2014836</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021 doi: 10.2139/ssrn.3820561.</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3820561</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Yao Q, Gu X, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021;398:747&#x2013;758. doi: 10.1016/S0140-6736(21)01755-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes DL, Holdsworth L, Jawad N, et al. Post-COVID-19 symptom burden: what is long-COVID and how should we manage it? Lung. 2021;199:113&#x2013;119. doi: 10.1007/s00408-021-00423-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-021-00423-z</ArticleId><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabacof L, Tosto-Mancuso J, Wood J, et al. Post-acute COVID-19 syndrome negatively impacts physical function, cognitive function, health-related quality of life, and participation. Am J Phys Med Rehabil. 2022;101:48&#x2013;52. doi: 10.1097/PHM.0000000000001910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHM.0000000000001910</ArticleId><ArticleId IdType="pmc">PMC8667685</ArticleId><ArticleId IdType="pubmed">34686631</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa Leite L, Carvalho L, Marcos de Queiroz D, Quintino Farias MS, Cavalheri V, Edgar DW, Ribeiro do Amaral Nery B, Vasconcelos Barros N, Maldaner V, Gurgel Campos N, Mesquita R. Can the post-COVID-19 functional status scale discriminate between patients with different levels of fatigue, quality of life and functional performance? Pulmonology. 2022;1:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8752288</ArticleId><ArticleId IdType="pubmed">35120866</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Cassar MP, Tunnicliffe EM, et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine. 2021 doi: 10.1016/j.eclinm.2020.100683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100683</ArticleId><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dyer AH, Jones K, et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE. 2020;15:1&#x2013;12. doi: 10.1371/journal.pone.0240784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240784</ArticleId><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavem K, Ghanima W, Olsen MK, et al. Prevalence and determinants of fatigue after covid-19 in non-hospitalized subjects: a population-based study. Int J Environ Res Public Health. 2021;18:1&#x2013;11. doi: 10.3390/ijerph18042030.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18042030</ArticleId><ArticleId IdType="pmc">PMC7921928</ArticleId><ArticleId IdType="pubmed">33669714</ArticleId></ArticleIdList></Reference><Reference><Citation>Shendy W, Maher-Ezzat M, Abdallah-ELaidy D, Abdelaziz-Elsherif A. Prevalence of fatigue in patients post COVID-19. European J Mol Clin Med. 2021;08:1330&#x2013;1340.</Citation></Reference><Reference><Citation>Calabria M, Garc&#xed;a C, Nicholas S, et al. Post-COVID-19 fatigue: the contribution of cognitive and neuropsychiatric symptoms. J Neurol. 2022 doi: 10.1007/s00415-022-11141-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-022-11141-8</ArticleId><ArticleId IdType="pmc">PMC9055007</ArticleId><ArticleId IdType="pubmed">35488918</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs LG, Paleoudis EG, Di BDL, et al. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS ONE. 2020;15:1&#x2013;14. doi: 10.1371/journal.pone.0243882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0243882</ArticleId><ArticleId IdType="pmc">PMC7732078</ArticleId><ArticleId IdType="pubmed">33306721</ArticleId></ArticleIdList></Reference><Reference><Citation>Krupp LB, Larocca NG, Muir Nash J, Steinberg AD. The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46:1121&#x2013;1123. doi: 10.1001/archneur.1989.00520460115022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1989.00520460115022</ArticleId><ArticleId IdType="pubmed">2803071</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerdal A (2022) Fatigue severity scale. In: Encyclopedia of quality of life and well-being research. Springer International Publishing, pp 1&#x2013;5.</Citation></Reference><Reference><Citation>Levin A, Malbeuf M, Hoens AM, et al. Creating a provincial post COVID-19 interdisciplinary clinical care network as a learning health system during the pandemic: integrating clinical care and research. Learn Health Syst. 2022 doi: 10.1002/lrh2.10316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lrh2.10316</ArticleId><ArticleId IdType="pmc">PMC9348470</ArticleId><ArticleId IdType="pubmed">35942206</ArticleId></ArticleIdList></Reference><Reference><Citation>Naik H, Malbeuf M, Levin A.&#xa0;Expanding the learning health care system beyond the academic health center. Acad Med. 2022 (In Press).</Citation><ArticleIdList><ArticleId IdType="pubmed">37797301</ArticleId></ArticleIdList></Reference><Reference><Citation>BC Centre for Disease Control. BC COVID-19 Situational Report Week 29. 2021.</Citation></Reference><Reference><Citation>Rossi D, Galant LH, Marroni CA. Psychometric property of fatigue severity scale and correlation with depression and quality of life in cirrhotics. Arq Gastroenterol. 2017;54:344&#x2013;348. doi: 10.1590/s0004-2803.201700000-85.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/s0004-2803.201700000-85</ArticleId><ArticleId IdType="pubmed">28977117</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitehead L. The measurement of fatigue in chronic illness: a systematic review of unidimensional and multidimensional fatigue measures. J Pain Symptom Manage. 2009;37:107&#x2013;128. doi: 10.1016/j.jpainsymman.2007.08.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpainsymman.2007.08.019</ArticleId><ArticleId IdType="pubmed">19111779</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosa K, Fu M, Gilles L, et al. Validation of the fatigue severity scale in chronic hepatitis C. Health Qual Life Outcomes. 2014;12:1&#x2013;12. doi: 10.1186/1477-7525-12-90.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1477-7525-12-90</ArticleId><ArticleId IdType="pmc">PMC4094687</ArticleId><ArticleId IdType="pubmed">24915781</ArticleId></ArticleIdList></Reference><Reference><Citation>Valko PO, Bassetti CL, Bloch KE, et al. Validation of the fatigue severity scale in a Swiss cohort. Sleep. 2008;31:1601&#x2013;1607. doi: 10.1093/sleep/31.11.1601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/sleep/31.11.1601</ArticleId><ArticleId IdType="pmc">PMC2579971</ArticleId><ArticleId IdType="pubmed">19014080</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) Qual Life Res. 2011;20:1727&#x2013;1736. doi: 10.1007/s11136-011-9903-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-011-9903-x</ArticleId><ArticleId IdType="pmc">PMC3220807</ArticleId><ArticleId IdType="pubmed">21479777</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie F, et al. A time trade-off-derived value set of the EQ-5D-5L for Canada. Med Care. 2016;54:98&#x2013;105. doi: 10.1097/MLR.0000000000000447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0000000000000447</ArticleId><ArticleId IdType="pmc">PMC4674140</ArticleId><ArticleId IdType="pubmed">26492214</ArticleId></ArticleIdList></Reference><Reference><Citation>Levis B, Sun Y, He C, et al. Accuracy of the PHQ-2 alone and in combination with the PHQ-9 for screening to detect major depression: systematic review and meta-analysis. JAMA J Am Med Assoc. 2020;323:2290&#x2013;2300. doi: 10.1001/jama.2020.6504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6504</ArticleId><ArticleId IdType="pmc">PMC7284301</ArticleId><ArticleId IdType="pubmed">32515813</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JBW. The patient health questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41:1284&#x2013;1292. doi: 10.1097/01.MLR.0000093487.78664.3C.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.MLR.0000093487.78664.3C</ArticleId><ArticleId IdType="pubmed">14583691</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman JH, Alves G, Hagell P, et al. Fatigue rating scales critique and recommendations by the movement disorders society task force on rating scales for Parkinson&#x2019;s disease. Mov Disord. 2010;25:805&#x2013;822. doi: 10.1002/mds.22989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.22989</ArticleId><ArticleId IdType="pubmed">20461797</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosti-Otaj&#xe4;rvi E, H&#xe4;m&#xe4;l&#xe4;inen P, Wiksten A, et al. Validity and reliability of the fatigue severity scale in finnish multiple sclerosis patients. Brain Behav. 2017;7:1&#x2013;8. doi: 10.1002/brb3.743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.743</ArticleId><ArticleId IdType="pmc">PMC5516613</ArticleId><ArticleId IdType="pubmed">28729945</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdulla FA, Al-Khamis FA, Alsulaiman AA, Alshami AM. Psychometric properties of an Arabic version of the fatigue severity scale in patients with stroke. Top Stroke Rehabil. 2019;26:448&#x2013;455. doi: 10.1080/10749357.2019.1628465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10749357.2019.1628465</ArticleId><ArticleId IdType="pubmed">31189456</ArticleId></ArticleIdList></Reference><Reference><Citation>Terwee CB, Bot SDM, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60:34&#x2013;42. doi: 10.1016/j.jclinepi.2006.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2006.03.012</ArticleId><ArticleId IdType="pubmed">17161752</ArticleId></ArticleIdList></Reference><Reference><Citation>Bland MJ, Altman DG. Cronbach&#x2019;s alpha. BMJ. 1997;314:572. doi: 10.1136/bmj.314.7080.572.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.314.7080.572</ArticleId><ArticleId IdType="pmc">PMC2126061</ArticleId><ArticleId IdType="pubmed">9055718</ArticleId></ArticleIdList></Reference><Reference><Citation>Streiner DL, Kottner J. Recommendations for reporting the results of studies of instrument and scale development and testing. J Adv Nurs. 2014;70:1970&#x2013;1979. doi: 10.1111/jan.12402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jan.12402</ArticleId><ArticleId IdType="pubmed">24684713</ArticleId></ArticleIdList></Reference><Reference><Citation>Boateng GO, Neilands TB, Frongillo EA, et al. Best practices for developing and validating scales for health, social, and behavioral research: a primer. Front Public Health. 2018 doi: 10.3389/fpubh.2018.00149.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2018.00149</ArticleId><ArticleId IdType="pmc">PMC6004510</ArticleId><ArticleId IdType="pubmed">29942800</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodwin E, Hawton A, Green C. Using the fatigue severity scale to inform healthcare decision-making in multiple sclerosis: mapping to three quality-adjusted life-year measures (EQ-5D-3L, SF-6D, MSIS-8D) Health Qual Life Outcomes. 2019;17:1&#x2013;12. doi: 10.1186/s12955-019-1205-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-019-1205-y</ArticleId><ArticleId IdType="pmc">PMC6683407</ArticleId><ArticleId IdType="pubmed">31382960</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard Landis J, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159&#x2013;174. doi: 10.2307/2529310.</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/2529310</ArticleId><ArticleId IdType="pubmed">843571</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention. Post-COVID Conditions. 2021;3.</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence (NICE). COVID-19 rapid guideline: managing the long-term effects of COVID-19. 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Schanke AK, Stanghelle JK. Fatigue in polio survivors. Spinal Cord. 2001;39:243&#x2013;251. doi: 10.1038/sj.sc.3101147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.sc.3101147</ArticleId><ArticleId IdType="pubmed">11438839</ArticleId></ArticleIdList></Reference><Reference><Citation>Galvez-S&#xe1;nchez CM, de la Coba PL, Duschek S, Del Paso GAR. Reliability, factor structure and predictive validity of the widespread pain index and symptom severity scales of the 2010 American college of rheumatology criteria of fibromyalgia. J Clin Med. 2020;9:1&#x2013;17. doi: 10.3390/jcm9082460.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9082460</ArticleId><ArticleId IdType="pmc">PMC7464133</ArticleId><ArticleId IdType="pubmed">32752048</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock KW, Wang XS, Wang S, et al. The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome. Quality Life Res. 2017 doi: 10.1007/s11136-016-1406-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-016-1406-3</ArticleId><ArticleId IdType="pmc">PMC5336422</ArticleId><ArticleId IdType="pubmed">27600520</ArticleId></ArticleIdList></Reference><Reference><Citation>Fluge &#xd8;, Rekeland IG, Lien K, et al. B-lymphocyte depletion in patients with myalgic encephalomyelitis/chronic fatigue syndrome. Ann Intern Med. 2019;170:585. doi: 10.7326/m18-1451.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/m18-1451</ArticleId><ArticleId IdType="pubmed">30934066</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim DY, Lee JS, Son CG. Systematic review of primary outcome measurements for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) in randomized controlled trials. J Clin Med. 2020;9:1&#x2013;12. doi: 10.3390/jcm9113463.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9113463</ArticleId><ArticleId IdType="pmc">PMC7692998</ArticleId><ArticleId IdType="pubmed">33126460</ArticleId></ArticleIdList></Reference><Reference><Citation>Veldhuijzen van Zanten J, Douglas MR, Ntoumanis N. Fatigue and fluctuations in physical and psychological wellbeing in people with multiple sclerosis: a longitudinal study. Mult Scler Relat Disord. 2021 doi: 10.1016/j.msard.2020.102602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2020.102602</ArticleId><ArticleId IdType="pubmed">33176231</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffith GJ, Morris TT, Tudball MJ, et al. Collider bias undermines our understanding of COVID-19 disease risk and severity. Nat Commun. 2020 doi: 10.1038/s41467-020-19478-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19478-2</ArticleId><ArticleId IdType="pmc">PMC7665028</ArticleId><ArticleId IdType="pubmed">33184277</ArticleId></ArticleIdList></Reference><Reference><Citation>Matta J, Wiernik E, Robineau O, et al. Association of self-reported COVID-19 infection and SARS-CoV-2 serology test results with persistent physical symptoms among French adults during the COVID-19 pandemic. JAMA Intern Med. 2022;182:19&#x2013;25. doi: 10.1001/jamainternmed.2021.6454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2021.6454</ArticleId><ArticleId IdType="pmc">PMC8576624</ArticleId><ArticleId IdType="pubmed">34747982</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>